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Abstract 
 
Background and aim On the basis of retrospective studies, hysterectomy has been 
considered a risk factor for functional bowel disorders. The aim of this study was to 
prospectively ĞǀĂůƵĂƚĞƚŚĞƉĂƚŝĞŶƚƐ ?ďŽǁĞůĨƵŶĐƚŝŽŶĂŶĚŐĞŶĞƌĂůŚĞĂůƚŚ-related quality of life 
(QoL) before and after hysterectomy. Our hypothesis was that hysterectomy in properly 
selected patients can impact positively ŽŶƚŚĞƉĂƚŝĞŶƚƐ ?ƐĞůĨ-reporting of their general health 
and bowel function. 
 
Materials and methods A prospective longitudinal observational study was conducted in a 
university-based teaching hospital. Eighty-five patients who were scheduled for total 
abdominal hysterectomy for a non-malignant cause completed the study. The main 
outcome measure was the ƉĂƚŝĞŶƚ ?ƐƉĞƌĐĞƉƚŝŽŶ of her bowel function, which was assessed 
preoperatively and at 6, 12, 26 and 52 weeks postoperatively using the gastrointestinal 
quality of life ƋƵĞƐƚŝŽŶŶĂŝƌĞ ?dŚĞƉĂƚŝĞŶƚ ?ƐŐĞŶĞƌĂůŚĞĂůƚŚ was also assessed using a generic 
general health questionnaire (EQ5D and EQVAS). The effect of time on change in 
questionnaire score was assessed using mixed model repeated measures at a significance 
level of 0.05. 
 
Results The scores in the three questionnaires declined significantly at 6 weeks 
postoperatively as compared with those obtained preoperatively. However, there was a 
subsequent increase in the scores up to 12 months postoperatively. Smoking and use of 
laxative were identified as potential confounding variables. 
 
Conclusion Apart from a transient negative effect, total abdominal hysterectomy improves 
ƚŚĞƉĂƚŝĞŶƚ ?Ɛgastrointestinal-related QoL, probably as part of general improvement in their 
QoL. 
 
 
Keywords: bowel, dysfunction, function, hysterectomy 
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Introduction 
As many as 100 000 hysterectomies [1,2] are performed annually in the UK. In the USA it has 
been estimated that by the age of 60, nearly one in three women would have undergone 
hysterectomy [3,4]. Common benign indications for hysterectomy include symptomatic 
fibroids, which are the most common uterine tumour and account for about 30% of all 
hysterectomies in women over the age of 30 [5,6]. Other causes include menorrhagia, 
dysmenorrhoea, endometriosis and chronic pelvic pain [5,6]. 
 
Over the years, various techniques for hysterectomy have been described reporting 
different benefits and complications [1,7 W9]. Complications of hysterectomy occur in nearly 
half of the abdominal hysterectomies [10]. The most common reported complications have 
been infection, haemorrhage, pain, thromboembolic events and unintended surgical 
procedures [11 W13]. Post hysterectomy complications have been related to several risk 
factors including age (very young or women over 70 years old), obesity, history of pelvic 
surgery [13,14] and parity [15]. Complications related to bowel, urinary and sexual function 
have received a great interest because of ƚŚĞŝƌŝŵƉĂĐƚŽŶƚŚĞǁŽŵĞŶ ?ƐƋƵĂůŝƚǇŽĨůŝĨĞ ?YŽ> ? ? 
 
Bowel dysfunction as a post hysterectomy complication was suggested in various 
retrospective studies in the late 1980s and early 1990s [16 W22]. However, the retrospective 
nature and lack of preoperative bowel function assessment limited the value of such 
studies. Numerous prospective studies ensued and were often contradictory 
[12,23 W33]. However, the lack of questionnaire validation [12,23,31 W33] affected the quality 
of such studies. Furthermore, nŽŶĞŚĂǀĞĞǆĂŵŝŶĞĚƚŚĞƉĂƚŝĞŶƚƐ ?symptoms in the context of 
global health or QoL, arguably the most important perspective from which to view 
symptoms (http://www.nice.org.uk/nicemedia/live/11927/39622/39622.pdf). 
 
The aim of this study was to prospectively assess the short-term and medium-term effect of 
total abdominal hysterectomy (TAH) on gastrointestinal function and general health-related 
QoL. 
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Materials and methods 
The study was approved by the Local Research Ethics Committee; it was peer reviewed and 
met all research governance requirements. In all, 100 women over the age of 18 years who 
were scheduled for TAH were recruited between March 2008 and April 2009. All patients 
were identified from their clinical records. Exclusion criteria included malignancy or radical 
hysterectomy. The operations were carried out at a university-based teaching hospital. 
Those who agreed to take part gave written consent and completed the first set of 
questionnaires ~2 weeks before their scheduled surgery, in the preoperative clinic. The 
operations were performed by an appropriately qualified surgeon. 
 
Patients were assessed symptomatically using validated generic gastrointestinal function 
and general health-related QoL questionnaires. 
 
Gastrointestinal quality of life index 
This is a validated disease-specific QoL questionnaire that was designed to assess 
gastrointestinal-related QoL [34]. Of the 36 questions, 19 are specific to gut function or the 
ability to eat and the remainder focussing on the impact of symptoms on social and sexual 
health and activities of daily living. Patients answer each question on a five-point scale of 
severity. The overall scores therefore range from 0 to 144; the higher the score, the better 
the paƚŝĞŶƚ ?ƐƉĞƌĐĞƉƚŝŽŶŽĨŚĞƌďŽǁĞůfunction [34]. The gastrointestinal quality of life index 
(GIQLI) has been used in several recent studies [35 W39]. 
 
EQ5D 
Formerly called the EuroQoL, the EQ5D is a generic, well-validated preference-based tool 
[40,41] that is used ƚŽŵĞĂƐƵƌĞƉĂƚŝĞŶƚƐ ?ƐĞůĨ-reported health-related QoL. It is a short and 
simple to use questionnaire, which is made up of two parts one of which is a visual analogue 
scale [42]. The EQ5D has also been used by other studies [43,44] to assess the QoL of 
patients before and after hysterectomy. 
 
The questionnaires were administered ~2 weeks before surgery at the preoperative clinic, 
and postoperatively at ~6, 12, 24 and 52 weeks. Reminders were sent to patients if no 
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response was obtained to the first questionnaire after 14 days. Demographic information 
was obtained from ƚŚĞƉĂƚŝĞŶƚ ?ƐŵĞĚŝĐĂůŶŽƚĞƐpostoperatively for statistical analysis. 
 
Statistical and data analysis 
The statistical package for social sciences for Windows, version 19 (SPSS Inc., Chicago, 
Illinois, USA) was used throughout the data analysis and significance was set at a level of 5% 
except where otherwise stated. A sample size of 53 and 85 achieves a 90% power to detect 
a difference of 10 and 5 points, respectively, at a significance level of 0.05 in the GIQLI 
scores from baseline, based on an estimated SD of 22 and 14, respectively. The 
questionnaires were scored according to their appropriate scoring algorithms and then 
summarized using descriptive statistics for each time point. The effect of time on the change 
in score from preoperative to 6 weeks postoperative and 12 months postoperative was 
assessed using mixed model repeated measures. Multiple linear regression was used to 
examine the effect of age, parity, BMI preoperative pelvic pain as an indication, duration of 
surgery, in-patient stay duration, use of laxatives postoperatively and oophorectomy on the 
outcome at 12 months postoperative. For each questionnaire, models were fitted with the 
change in score from preoperative to 12 months postoperative as the dependent variable 
and the possible confounding variable and the preoperative score as the independent 
variables. 
 
Results 
A total of 100 patients were recruited at the baseline. However, 15 were excluded by the 
end of the study in July 2010 for the following reasons: one operation was cancelled, four 
patients had subtotal hysterectomy and 10 had dropped out. Dropouts were defined as 
those who did not respond or returned at least one of the postoperative questionnaires 
blank. Figure 1 is a flow diagram of the patients who approached, recruited and completed 
the study. Demographic information was obtained from the ƉĂƚŝĞŶƚ ?ƐŵĞĚŝĐĂůŶŽƚĞƐ before 
and after surgery. Mean (SD) age and BMI were 46.5 (5.6) years and 28.2 (5.4) kg/m², 
respectively. The median parity was 2. 
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Indications 
The most common indications for surgery were menorrhagia (69.4%), fibroids (55%), 
dysmenorrhoea and pelvic pain (29.6%), endometriosis (14%), abnormal uterine bleeding 
(11%) and ovarian mass (12%). Some women had more than one symptomatic indication 
hence the total exceeds 100%. 
 
Intraoperative and postoperative events and complications of total abdominal 
hysterectomy 
The duration of the operation ranged from 30 to 180 min, with an average of 95 min. The 
range of hospital stay was between 3 and 11 days; one ƉĂƚŝĞŶƚ ?ƐƐƚĂǇĚƵƌĂƚŝŽŶůĂƐƚĞĚfor 11 
days because she had to be taken back to theatre for another surgical procedure. All other 
patients were admitted for a duration ranging between 3 and 6 days. Intraoperative blood 
loss was visually estimated from the swabs used during the operation and the contents of 
the suction apparatus receiver (Table 1). 
 
Changes in quality of life measures 
Examination of the mean [95% confidence interval (CI)] of the questionnaire scores in Table 
2 and Fig. 2 shows a decline in the scores of the three questionnaires at 6 weeks 
postoperative compared with the preoperative scores. The longitudinal model shows that 
this change was statistically significant for the EQ5D ( W 0.07, 95% CI:  W 0.12 to  W 0.29, 
P=0.001) but not statistically significant for the GIQLI ( W 6.6, 95% CI:  W 13.2 to 0.1, P=0.055) 
nor the EQVAS ( W 0.4, 95% CI:  W 9.9 to 1.9, P=0.184). However, there were overall increases 
in the scores of the three questionnaires at 12 months postoperative compared with the 
preoperative scores. The longitudinal model shows that these changes are statistically 
significant for the GIQLI (13.1, 95% CI: 6.2 W20.1, P<0.001), the EQ5D (0.05, 95% CI: 
0.004 W0.09, P=0.031) and the EQVAS (7.1, 95% CI: 1.2 W13.1, P=0.019). 
 
The analysis of the confounding variables found a statistically significant difference in the 
12-month change of GIQLI scores between smokers compared with non-smokers ( W 14.4, 
95% CI:  W 24.8 to  W 3.9, P=0.008) and a statistically significant difference in the 12-month 
change of EQ5D scores between those who used laxatives postoperatively compared with 
those who did not (0.05, 95% CI: 0.001 W0.10, P=0.048). None of the other potential 
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confounding variables made a statistically significant difference to the 12-month change in 
scores. 
 
Discussion 
The study prospectively assessed the self-reported bowel function and general health status 
of women undergoing TAH for benign conditions preoperatively and up to a year 
postoperatively and showed no overall detrimental short-term and medium-term effects of 
TAH on bowel function. All the patients were treated in the same centre, assessed before 
and after hysterectomy, and were seen more frequently in the first year than any previous 
study. 
 
Concerns about the possibility of adverse effects of hysterectomy on bowel function are 
well founded. Surgical injury to the inferior hypogastric plexus, intimately related to the 
cervix, cardinal and uterosacral ligaments might affect the autonomic innervation of the 
distal colon [22,45,46]. Damage to the fibromuscular pelvic floor and traction injury to the 
pudendal nerve could lead to abnormalities of pelvic descent during defecation [47,48] and 
the development of enterocele or rectocele giving rise to symptoms of obstructed 
defecation or incontinence [47,48]. 
 
Accordingly, it has been commonly thought that women with gynaecological symptoms 
concomitantly suffer from bowel dysfunction, particularly those with a previous history of 
gynaecological surgery based on retrospective evidence [23,49,50]. 
 
Our study shows that after a transient deterioration in QoL and bowel function 
postoperatively, both gastrointestinal-specific and general QoL indices improved at 12 
weeks and were sustained at 6 and 12 months. The 6-week deterioration is likely to reflect 
incomplete resolution of symptoms occurring as a consequence of surgery. Subsequent 
sustained improvement suggests that hysterectomy per se is not associated with a long-
term detrimental effect on gut function when patients are carefully selected for surgery. 
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It is interesting to speculate why this study demonstrates a more favourable outcome than 
some previously published studies. More conservative treatment modalities for the 
management of menorrhagia, a common indication for hysterectomy, have emerged in the 
last two decades, and this might indicate that surgeons are selecting more appropriate 
patients to offer hysterectomy, thus resulting in a better outcome. 
 
It is possible that further change in bowel function might occur beyond the 1-year follow-up 
period used in this study. Previous prospective studies on posthysterectomy patients have 
performed reassessments after as little as 16 weeks [25] and as long as 3 years, but the 
majority of the studies have been up to a maximum of 1 year postoperatively [8,26,27,30 W
33]. Furthermore, one study that assessed patients at both 1 and 3 years postoperatively 
[28] showed an increased risk of anal incontinence after hysterectomy, but this was evident 
at 1 year and persisted at 3 years and there were no other differences in bowel function 
preoperatively and postoperatively or between the two time periods. Nonetheless, it 
remains possible that further changes may manifest in time. 
 
It has been reported that young age at hysterectomy impacts psychological well-being [51], 
which was not observed in this study. The GIQLI and EQ5D are not specific measures of 
psychological well-being; however, both contain specific domains containing questions 
about mental well-being that contribute to the overall scores. 
 
Conclusion 
TAH has a transient negative effecƚŽŶƉĂƚŝĞŶƚƐ ?ŐĂƐƚƌŽŝŶƚĞƐƚŝŶĂůQoL, which gradually 
resolves. Patient selection and preoperative assessment may explain previous reports of 
hysterectomy having an adverse effect on bowel function. 
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Table 1: Operative and postoperative data 
Variables  
Duration of surgery (minutes)  
Mean ± SD 95.48 ± 31.172 
Median  95 
Range 30 Ȃ 180  
Duration of hospital stay (days) Ȃ including days of admission and discharge  
Mean ± SD 4.83 ± 1.316 
Median  5 
Range 3 Ȃ 11  
Estimated blood loss (mls)  
Mean ± SD 393.59 ± 303.803 
Median  300 
Range 100 Ȃ 2500  
Concomitant procedures  Total number (%) 
Adhesiolysis 6 (7.1) 
Omentectomy 3 (3.6) 
Cystoscopy 2 (2.4) 
Ureteral stenting 1 (1.2) 
Colpo-suspension 1 (1.2) 
Postoperative events:  
Use of laxatives 28 (33.3) 
Pyrexia (both explained and unexplained) 15 (17.9) 
Wind pain 12 (14.3) 
Haematuria 10 (11.9) 
UTI 3 (3.6) 
Wound haematoma 3 (3.6) 
Faecal incontinence 1 (1.2) 
2ry Haemorrhage  1 (1.2) 
Re-admission to hospital 1 (1.2) 
Wound dehiscence 1 (1.2) 
Ovary status  
Bilateral oopherectomy 45 (52.9) 
Unilateral oopherectomy 9 (10.5) 
No oopherectomy 31 (36.5) 
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Table 2: Summary statistics of questionnaire scores 
 N Mean SD Median 95% CI 
Confidence 
Interval 
GIQLI scores      
GIQLI scores at preop 77 105.6 20.4 109.0 100.9 - 110.2 
GIQLI score at 6 wks 67 99.0 20.2 106.0 94.1 Ȃ 103.9 
GIQLI score at 12wks 74 110.3 20.5 116.5 105.6 Ȃ 115.1 
GIQLI score at 24wks 63 117.4 19.1 125.0 112.6 Ȃ 122.2 
GIQLI score at 52wks 62 118.7 20.8 126.0 113.4 Ȃ 124.0 
EQ-5D      
EQ-5D at preop 84 0.87 0.13 0.84 0.84 Ȃ 0.90 
EQ-5D at 6wks 72 0.80 0.14 0.82 0.76 Ȃ 0.83 
EQ-5D at 12wks 75 0.88 0.12 0.84 0.85 Ȃ 0.90 
EQ-5D at 24wks 65 0.89 0.14 1.00 0.86 Ȃ 0.93 
EQ-5D at 52wks 65 0.92 0.13 1.00 0.88 Ȃ 0.95 
EQ-VAS      
EQ-VAS score at preop 77 76.3 18.6 80.0 72.0 Ȃ 80.5 
EQ-VAS score at 6wks 66 72.3 17.0 78.0 68.1 Ȃ 76.5 
EQ-VAS score at 12wks 68 78.4 19.5 84.5 73.7 Ȃ 83.1 
EQ-VAS score at 24wks 61 84.6 13.0 90.0 81.3 Ȃ 78.9 
EQ-VAS score at 52wks 57 83.4 16.1 89.0 79.1 Ȃ 87.7 
N = the number of patients who completed the questionnaires at all time periods  
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Figure 1: Patients͛ responses to questionnaires 
 
  
ȈExcluded: Ȉ1 cancelled operation  Ȉ4 subtotal hysterectomy Ȉ10 drop-outs 100 patients originally recruited 
ȈMissing data  Ȉ8 from GIQLI Ȉ1 from EQ-5D Ȉ8 from EQ-VA 85 remaining patients from preop 
ȈMissing data Ȉ8 from GIQLI Ȉ3 from EQ-5D Ȉ9 from EQ-VAS 75 responses at 6weeks 
ȈMissing data Ȉ1 from GIQLI Ȉ0 from EQ-5D Ȉ7 from EQ-VAS 75 responses at 12weeks 
ȈMissing data Ȉ5 from GIQLI Ȉ3 from EQ-5D Ȉ7 from EQ-VAS 68 responses at 24weeks 
ȈMissing data Ȉ3 from GIQLI Ȉ0 from EQ-5D Ȉ8 from EQ-VAS 65 responses at 52weeks 
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Figure 2: Mean questionnaire scores and 95% confidence intervals. (a) GIQLI, 
gastrointestinal quality of life index; (b) EQ5D; and (c) EQVAS 
 
